32 results on '"Eisenhauer E"'
Search Results
2. A Population-Based Study of Melanoma Brain Metastasis Treatment: Has Progress in Systemic Therapy and Radiation Therapy Improved Patient Outcomes?
3. The Evidence Driven Dosimetric Constraints From Outcome Analysis of H&N Patients’ Data from NRG Oncology RTOG 0522 Trial
4. Abstract number 3: Contraception practice & pregnancy risk assessment among gynecologic oncologists for reproductive age patients: A retrospective review
5. Abstract number 1: The futility of transvaginal ultrasound in type II endometrial cancer
6. Reducing readmissions after robotic surgical management of endometrial cancer: A potential for improved quality care
7. Predicting patients requiring prolonged hospitalization after robotic surgery for the management of endometrial cancer: An opportunity for improvement
8. Abstract 11: Does adjuvant therapy improve survival for early stage leiomyosarcoma?
9. A phase I study of intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in patients with previously untreated epithelial ovarian carcinoma or primary peritoneal carcinoma
10. Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer – A phase I study
11. Does IORT at the time of pelvic exenteration impact survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
12. Does adjuvant therapy improve survival for early stage leiomyosarcoma?
13. Does comprehensive staging make a difference for recurrence and survival of patients with high-intermediate risk endometrial cancer?
14. Are postmenopausal women with body mass indices < 30 with grade 1 endometrial cancer more likely than their obese counterparts to have advanced or recurrent disease?
15. Preoperative tumor grade and intraoperative tumor size identifies patients at intermediate risk for lymph node involvement but not necessarily those at increased risk of recurrence
16. Prospective evaluation of postoperative pain and quality of recovery in patients undergoing robotic vs. laparotomy for staging of endometrial cancer
17. A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced stage endometrial carcinoma
18. Expression patterns of the Wnt pathway inhibitor dickKOPF-3 (Dkk3) and secreted frizzled-related proteins (sFRP) 1 and 4 in endometrial endometrioid adenocarcinoma: A gynecologic oncology group study
19. Complications After Double-Barreled Wet-Ostomy Compared to Separate Urinary and Fecal Diversion During Pelvic Exenteration: Time to Change Back?
20. Endometrial cancer staging in the elderly: Robotic or open?
21. Expression patterns of the Wnt pathway inhibitors Dickkopf3 (Dkk3) and secreted frizzled-related proteins (SFRP) 1 and 4 in endometrial endometrioid adenocarcinoma: A Gynecologic Oncology Group study
22. Complications after double-barreled wet-ostomy compared to separate urinary and fecal diversion during pelvic exenteration: Time to change back?
23. Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
24. Retreatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen (BCR) significantly improves PFS in patients with EOC
25. Can cold knife cone pathologic specimens safely predict parametrial involvement?
26. When are surgical margins after radical hysterectomy too close?
27. Expression patterns of p53 and p21 cell cycle regulators and clinical outcome in women with pure gynecologic sarcomas
28. Uterine leiomyosarcoma: Can locoregional recurrences be salvaged by surgery and additional therapies?
29. A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced-stage endometrial carcinoma: Report of toxicity
30. A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
31. Postoperative Seromas Following Robotic/Laparoscopic Lymph Node Dissection in Patients with Radiation/Chemotherapy for Gynecologic Cancers
32. A phase I study of GM-CSF, cyclophosphamide (CP), and escalating doses of carboplatin (CBDCA) in chemotherapy-Naïve patients with ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.